VBData· 动脉网-最新·· 6 hours agoPickScore74
Merck KGaA to Acquire UK siRNA Company Silence Therapeutics for About $1.3 Billion in Cash
In brief
Merck KGaA of Darmstadt, Germany, announced on October 19 an all-cash acquisition of UK-based Silence Therapeutics for approximately $1.3 billion, offering $20 per ADS, a 130% premium over the October 16 closing price. The deal is expected to close in the first quarter of 2027, subject to shareholder and regulatory approvals.
Why it matters
The source reports the deal terms together with divesiran Phase 2 data and the mRNAi GOLD platform pipeline, helping readers place the acquisition in the broader siRNA competitive landscape.
Source: VBData